Fundz

Allyx Therapeutics reported raising $2.31 Million in an initial SEC Form D filing, from an offering of $2.31 Million

PRIVATEFeb 10, 2023

Amount Raised

$2.31 Million

$2.31 Million sold, per SEC Form D (first sale Feb 3, 2023)

Round Type

Seed

New HavenBiotechnology

Quick answer

Allyx Therapeutics raised $2.31 Million in a Seed round, dated February 3, 2023. Allyx Therapeutics is based in New Haven, Connecticut, United States.

How much did Allyx Therapeutics raise?
Allyx Therapeutics raised $2.31 Million in a Seed round on February 3, 2023.
What does Allyx Therapeutics do?
Allyx Therapeutics is a clinical stage biotechnology company aiming to develop disease modifying therapies for Alzheimer's disease by targeting the underlying cause of synapse loss.
Where is Allyx Therapeutics based and how big is it?
Allyx Therapeutics is based in New Haven, Connecticut, United States. Fundz records about 5 employees.
Who are the decision-makers at Allyx Therapeutics?
Fundz holds 1 contact at Allyx Therapeutics, including the Vice President Clinical Operations. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Allyx Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • CalciMedica raised $10M on March 20, 2023.
  • CalciMedica raised $9.1M on March 20, 2023.
  • AERA Health raised $4.3M (Seed) on March 20, 2023.
  • GT Medical Technologies raised $37M on March 20, 2023.
  • Microbix Biosystems Inc. raised an undisclosed amount (Funding Round) on March 20, 2023.
  • Clarapath raised $11M on March 20, 2023.

Who to call at Allyx Therapeutics, and when

A new round usually means Allyx Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Allyx Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Allyx Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Allyx Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Allyx Therapeutics

Location

470 JAMES STREET

New Haven, Connecticut, United States

About

Allyx Therapeutics is a clinical stage biotechnology company aiming to develop disease modifying therapies for Alzheimer's disease by targeting the underlying cause of synapse loss.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Allyx Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPatrick S., Vice President Clinical OperationsSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Allyx Therapeutics's next move

See what Strategic adds

Allyx Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.